NASDAQ · Healthcare · Biotechnology
Corvus Pharmaceuticals, Inc.
CRVS
Corvus Pharmaceuticals, Inc. CEO Richard A. Miller · Market cap $1.2B.
$14.46
+0.13 · +0.91%
52w hi $26.9552w lo $5.28
Off 52w high 55.8%
63
NOTABLE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
1
0 strong · 1 notable
Analyst consensus
Strong Buy
Avg PT $33.17
Section 01
Recent Form 4 filings
4 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jun 11 | David Scott Moore | Buy | 21,700 | $11.53 | +$250K | 63 | |
| May 18 | Richard A Miller MD | President and CEO | Buy | 5,000 | $12.05 | +$60K | 58 |
| Jun 27 | Peter A. Thompson | Sell | 1,176,332 | $4.16 | −$4.89M | 32 | |
| Jun 27 | ORBIMED ADVISORS LLC | Sell | 1,176,332 | $4.16 | −$4.89M | 32 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug